The legacy of the blue pill offers a complex case study for stakeholders eyeing the pharmaceutical sector. While first sales were remarkable, current patent expiry and the rise of cheaper versions have severely https://alexiaojin524163.affiliatblogger.com/93413793/viagra-and-the-pharmaceutical-industry-a-risky-stake